cell membrane-anchored/CSV-targeted IL-12-expressing T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-012506
A preparation of T lymphocytes engineered to express cell membrane-anchored and cell-surface vimentin (CSV)-targeted interleukin-12 (IL-12), with potential immunostimulatory and antineoplastic activities. Upon administration, the cell membrane-anchored/CSV-targeted IL-12-expressing T lymphocytes are directed to and induce selective toxicity in CSV-expressing tumor cells. The cell membrane-anchored IL-12 cytokine promotes the secretion of interferon-gamma (IFNg), activates natural killer cells (NKs), and induces cytotoxic T-lymphocyte (CTL) responses against tumor cells locally, which may result in immune-mediated tumor cell death and the inhibition of tumor cell proliferation. Vimentin, overexpressed in various tumors, is associated with tumor growth and metastasis. Cell membrane-anchored IL-12 reduces the circulating levels of the inflammatory cytokine and the associated systemic adverse effects.
| Identifier | MLC-T-ONC-012506 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | attIL12 armed T cells; attIL12-expressing T-cells; attIL12-T cells; cell membrane-anchored/tumor-targeted IL-12-expressing T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012506",
"term": "cell membrane-anchored/CSV-targeted IL-12-expressing T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of T lymphocytes engineered to express cell membrane-anchored and cell-surface vimentin (CSV)-targeted interleukin-12 (IL-12), with potential immunostimulatory and antineoplastic activities. Upon administration, the cell membrane-anchored/CSV-targeted IL-12-expressing T lymphocytes are directed to and induce selective toxicity in CSV-expressing tumor cells. The cell membrane-anchored IL-12 cytokine promotes the secretion of interferon-gamma (IFNg), activates natural killer cells (NKs), and induces cytotoxic T-lymphocyte (CTL) responses against tumor cells locally, which may result in immune-mediated tumor cell death and the inhibition of tumor cell proliferation. Vimentin, overexpressed in various tumors, is associated with tumor growth and metastasis. Cell membrane-anchored IL-12 reduces the circulating levels of the inflammatory cytokine and the associated systemic adverse effects.",
"synonyms": [
"attIL12 armed T cells",
"attIL12-expressing T-cells",
"attIL12-T cells",
"cell membrane-anchored/tumor-targeted IL-12-expressing T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cell-membrane-anchored-csv-targeted-il-12-expressing-t-lymphocytes/"
}
Record 4,555 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.